Navigation Links
Carnegie Mellon receives $1.85 million
Date:2/7/2008

PITTSBURGH With a $1.85 million grant from the New York-based Doris Duke Charitable Foundation (DDCF), Carnegie Mellon Universitys M. Granger Morgan will lead a team of investigators from Carnegie Mellon, the University of Minnesota, the Vermont Law School and the Washington, D.C.-based energy law firm Van Ness Feldman to develop and promote a regulatory structure for the safe and economical capture, transport and deep geological sequestration of carbon dioxide (CO2) in the United States.

Morgan and his colleagues note that CO2 can be removed from coal or natural gas in variety of ways before or after combustion. Once it is removed, it can be deposited deep underground in appropriate geological formations. Most of the technologies for doing this exist today at commercial scale, but have not yet been combined for power plants. The National Energy Technology Laboratory (NETL) in Pittsburgh and Morgantown, W.Va., is supporting much of the research that is needed to make such processes commercially viable.

Getting the technology right is important, Morgan said. But if the U.S. is going to put large quantities of CO2 underground, we need to be sure it is done in a safe and effective way.

Morgan and his colleagues argue that before any definitive regulations can be developed, the U.S. must first get experience with several commercial-scale facilities. For this reason, developing an adaptive, two-stage approach to regulation will be a key part of the new DDCF-supported project.

This grant is further recognition of the great strength that Carnegie Mellon has built up in technically-focused work in energy policy, said Pradeep K. Khosla, dean of the College of Engineering at Carnegie Mellon.

Previous work done by Carnegie Mellons Ed Rubin and his colleagues on modeling carbon capture, by Jay Apt, Lester Lave and Paul Fischbeck on the electricity industry, and by investigators associated with our NSF-supported Center for Climate Decision Making, have laid the groundwork that makes us the obvious choice to do this kind of work, Khosla said.

The grant to Carnegie Mellon is part of a $100 million Climate Change Initiative created by the DDCF to develop new energy technologies that can help society reduce greenhouse gas emissions and create a cleaner economy.

By focusing these grants on how energy technology innovation occurs and how it can be improved through better policy, the aim is to ensure that tomorrows clean energy technologies emerge on an accelerated timeline, said Andrew Bowman, director of the DDCFs Climate Change Initiative.

The grants, totaling more than $6.6 million to an elite group of research universities and policy think tanks nationwide, support research in two categories. The first set will assess the innovation systems already in place for energy technologies and suggest improvements to policies that guide this type of research. The second group of research grants will address ways new technologies can quickly be brought on line.


'/>"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
Source:Eurekalert

Related biology news :

1. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
4. Carnegie Mellon, Pitt Team to study psychosocial stress
5. Mellon awards Carnegie Grant for Ecological Monitoring in South Africa
6. Carnegie Mellon researchers to develop new drug delivery system
7. Carnegie Mellon students win contest
8. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
9. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
10. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
11. Rutgers Genetics receives $7.8 million for autism research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
Breaking Biology News(10 mins):
(Date:6/22/2016)...  According to Kalorama Information, the dominant trends ... include significant efforts in automation as well as ... affordable sequencers, say the healthcare market research firm, ... sample prep materials.  The healthcare market research company,s ... Next Generation Sequencing (NGS) , highlights major trends ...
(Date:6/22/2016)... DIEGO , June 22, 2016   ViaCyte, ... first pluripotent stem cell-derived islet replacement therapy for the ... presentations at ISSCR 2016 Annual Meeting.  ISSCR 2016, the ... to 25th at Moscone West in San Francisco.  ... of the presentations are as follows:Event: , Focus Session: ...
(Date:6/22/2016)... 22, 2016  Mesa Biotech Inc., a privately-held, ... platform designed specifically for point-of-care (POC) infectious disease ... advisory board (SAB). Approved by the executive leadership ... chartered to advise on the development and commercialization ... by Dr. Steve Young , this world-class ...
(Date:6/21/2016)... , June 22, 2016 Frontier Biotechnologies Inc. ... its novel patch product AB001 met primary endpoint at ... relief against placebo. Conducted at nine clinical centers in ... enrolled 146 patients with chronic low back pain. AB001 ... week-1 (p=0.024), (2) greater reduction than placebo in the ...
Breaking Biology Technology: